Neurological Research · 2013 · 36 citations · 18 references
We conclude that patients with ACI have an upregulated CD40-CD40L system, which could be used as a clinical biomarker for assessing atherosclerotic instability and severity of neurological dysfunction.
18
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
François Mach, Uwe Schönbeck, Galina K. Sukhova et al. · Nature · 1998 · 912 citations
Soluble CD40 Ligand in Acute Coronary Syndromes
Christopher Heeschen, Stefanie Dimmeler, Christian W. Hamm et al. · New England Journal of Medicine · 2003 · 824 citations · Full text